Every cell and every organism ages sooner or later. But why is this so? Scientists at the German Cancer Research Center in Heidelberg have now discovered for the first time a protein that represents a central switching point in the aging process. It controls the life span of an individual – from the fly to the human being. This opens up new possibilities for developing therapies against age-related diseases.
Oxidative stress causes cells and entire organisms to age. If reactive oxygen species accumulate, this causes damage to the DNA as well as changes in the protein molecules and lipids in the cell. The cell ultimately loses its functionality and dies. Over time, the tissue suffers and the body ages. “The theory of oxidative stress or the accumulation of reactive oxygen species as the cause of aging has existed since the 1950s,” says Peter Krammer of the German Cancer Research Center (DKFZ). “So far, however, the details of this process were unclear.”
In fact, reactive oxygen species do more than just damage the body. For example, they are essential for the T-cells of the immune system to become active. DKFZ researchers led by Krammer and Karsten Gülow* have now discovered the key regulator that is responsible for shifting the sensitive balance from vital to harmful amounts of reactive oxygen molecules and thus accelerating the aging process: A protein molecule called TXNIP (thioredoxin-interacting protein).
One way in which the body disposes of harmful reactive oxygen species is their conversion by the enzyme thioredoxin-1 (TRX-1). TRX-1 has been proven to play a role in protecting DNA from oxidative stress and slowing down aging processes. Its antagonist TXNIP inhibits thioredoxin-1 and thus ensures that the reactive oxygen molecules are retained.
The DKFZ researchers led by Krammer and Gülow now wanted to know whether more TXNIP is formed in the body with increasing age, thereby undermining the protective mechanism against oxidative stress. To this end, they first compared T cells from the blood of a group of over 55-year-old volunteers with the T cells of younger blood donors, who were between 20 and 25 years old. In fact, it turned out that the cells of older subjects produce significantly more TXNIP. The DKFZ scientists have also observed similar findings in other human cell and tissue types.
The researchers also found out that more TXNIP is produced in the fly Drosophila with increasing age. In order to test whether TXNIP is actually responsible for aging, they bred flies that produce significantly more TXNIP than their relatives as well as flies in which TXNIP synthesis is greatly reduced. “Flies that produced more TXNIP lived on average much shorter, while flies with less TXNIP had a longer average life,” sums up Tina Oberacker, who was responsible for the fly experiments.
“TRX-1 and its opponent TXNIP are highly conserved in the course of evolution; they hardly differ between flies and humans,” explains Krammer. It can therefore be assumed that the two proteins perform similar functions in flies and humans. If more TXNIP is produced with increasing age, this means that TRX is gradually switched off with its protection function. This leads to more oxidative stress, which damages cells and tissue and eventually causes them to die.
Krammer is convinced that TXNIP is a key regulator for aging. “Scientists have found hundreds of genes that are somehow related to the aging process,” says the DKFZ researcher summarizing the results. “But it is enough to switch off TXNIP to delay aging. Similarly, aging can be accelerated if we get the cells to produce TXNIP. “And that makes it an interesting candidate to intervene in the aging process in the future.”
Learn more: Key molecule of aging discovered
The Latest on: Regulator for aging
via Google News
The Latest on: Regulator for aging
- Can we end aging via science and supplements? I put it to the test - on myself - and this is what I found out.on October 7, 2020 at 2:40 pm
The quest for immortality is as old as time itself. But what can we do now to live longer, healthier lives? I embarked on a 12-week longevity experiment to see if I could alter my longevity biomarkers ...
- Delta IV Heavy rocket delayed again, raising concerns of aging infrastructureon September 30, 2020 at 6:56 am
On Tuesday evening, just hours before the company's latest attempt to launch the large Delta IV Heavy booster, the mission was scrubbed again. The weather at the launch site was far from optimal, but ...
- EPFL scientists measure the molecular footprint of agingon September 29, 2020 at 4:24 pm
EPFL scientists have measured the molecular footprint that aging leaves on various mouse and human tissues. Using the data, they have identified likely regulators of this central process.
- Understanding the effect of aging on the genomeon September 28, 2020 at 5:00 pm
Scientists have measured the molecular footprint that aging leaves on various mouse and human tissues. Using the data, they have identified likely regulators of this central process.
- Researchers uncover epigenetic drivers for Alzheimer's diseaseon September 28, 2020 at 1:10 pm
New findings suggest that late-onset Alzheimer's Disease is driven by epigenetic changes—how and when certain genes are turned on and off—in the brain. Results were published today in Nature Genetics.
- Penn researchers uncover epigenetic drivers for Alzheimer's diseaseon September 28, 2020 at 11:24 am
New findings suggest that late-onset Alzheimer's Disease is driven by epigenetic changes -- how and when certain genes are turned on and off -- in the brain. Results were published today in Nature ...
- Epigenetic drivers for Alzheimer's disease uncoveredon September 27, 2020 at 5:00 pm
New findings suggest that late-onset Alzheimer's Disease is driven by epigenetic changes -- how and when certain genes are turned on and off -- in the brain.
- Dr. Malene Hansen receives 2020 BIG Awardon September 21, 2020 at 5:00 pm
elegans, as well as mammalian cell culture systems to unravel how evolutionarily conserved pathways affect aging, and has identified several genes and regulators that may facilitate future ...
- Conquering Metabesity: What Does The Government Do For The Longevity Of Their Citizens?on September 18, 2020 at 12:20 am
Dr. Alexander Fleming: First, regulators, medicine, industry and the general population have not historically viewed aging as a disease or condition to be treated or cured, but rather as an ...
via Bing News